COVID-19 Prevention Trial: Effect of Prophylactic Use of TAFFIX™ on Infection Rate by SARS-CoV-2 Virus (COVID-19).
Clinical trial NCT05252468 · COMPLETED
Trial details
- NCT number
- NCT05252468
- Sponsor
- Nasus Pharma
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-19
- Primary completion
- 2021-11-02
- Enrollment
- 693
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.